Screening of GPCR drugs for repurposing in breast cancer

• Главные авторы: Noor Mazin Abdulkareem (Автор), Raksha Bhat (Автор), Reid T. Powell (Автор), Soumya Chikermane (Автор), Soham Yande (Автор), Lisa Trinh (Автор), Hala Y. Abdelnasser (Автор), Mantasha Tabassum (Автор), Alexis Ruiz (Автор), Mary Sobieski (Автор), Nghi D. Nguyen (Автор), Jun Hyoung Park (Автор), Camille A. Johnson (Автор), Benny A. Kaipparettu (Автор), Richard A. Bond (Автор), Michael Johnson (Автор), Clifford Stephan (Автор), Meghana V. Trivedi (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Drug repurposing can overcome both substantial costs and the lengthy process of new drug discovery and development in cancer treatment. Some Food and Drug Administration (FDA)-approved drugs have been found to have the potential to be repurposed as anti-cancer drugs. However, the progress is slow du...